help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MCEVOY, C. E.
Right arrow Articles by NIEWOEHNER, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MCEVOY, C. E.
Right arrow Articles by NIEWOEHNER, D. E.

Am. J. Respir. Crit. Care Med., Volume 157, Number 3, March 1998, 704-709

Association between Corticosteroid Use and Vertebral Fractures in Older Men with Chronic Obstructive Pulmonary Disease

CHARLENE E. MCEVOY, KRISTINE E. ENSRUD, EARL BENDER, HARRY K. GENANT, WEI YU, JAYNE M. GRIFFITH, and DENNIS E. NIEWOEHNER

Section of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Minnesota Medical School; Sections of General Internal Medicine and Pulmonary Medicine, Department of Medicine, and Department of Radiology, VA Medical Center; Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, Minnesota; and Departments of Radiology and Medicine, University of California, San Francisco, California

Osteoporosis is a major complication of long-term corticosteroid administration, but the magnitude of the effect in patients with chronic obstructive pulmonary disease (COPD) is not well defined. In a cross-sectional study, we evaluated the association between steroid use and vertebral fractures in 312 men, 50 yr of age or older, with COPD. Subjects were evaluated according to their corticosteroid use: Never Steroid Users (NSU) (n = 117), Inhaled Steroid Users (ISU) (n = 70), and Systemic Steroid Users (SSU) (n = 125). The prevalence of one or more vertebral fractures was 48.7% in the NSU group, 57.1% in the ISU group, and 63.3% in the SSU group. Compared with NSU, SSU were two times as likely to have one or more vertebral fractures: age-adjusted odds ratio (OR) = 1.80; 95% CI, 1.08 to 3.07. This relationship was primarily due to a strong association between continuous systemic steroid use and vertebral fractures: age-adjusted OR = 2.36; 95% CI, 1.26 to 4.38. In addition, fractures in SSU were more likely to be multiple and more severe. A weaker relationship existed between inhaled steroid use and vertebral fractures: age-adjusted OR = 1.35; 95% CI, 0.77 to 2.56 compared with NSU. These data indicate that vertebral fractures are common in older men with COPD; the likelihood of these fractures is greatest in those men using continuous systemic steroids. McEvoy CE, Ensrud KE, Bender E, Genant HK, Yu W, Griffith JM, Niewoehner DE. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease.




This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Kjensli, J. A. Falch, M. Ryg, T. Blenk, G. Armbrecht, L. M. Diep, and I. Ellingsen
High prevalence of vertebral deformities in COPD patients: relationship to disease severity
Eur. Respir. J., May 1, 2009; 33(5): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Togo, O. Holz, X. Liu, H. Sugiura, K. Kamio, X. Wang, S. Kawasaki, Y. Ahn, K. Fredriksson, C. M. Skold, et al.
Lung Fibroblast Repair Functions in Patients with Chronic Obstructive Pulmonary Disease Are Altered by Multiple Mechanisms
Am. J. Respir. Crit. Care Med., August 1, 2008; 178(3): 248 - 260.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make
Comorbidities in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, May 1, 2008; 5(4): 549 - 555.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. M. Fabbri, F. Luppi, B. Beghe, and K. F. Rabe
Complex chronic comorbidities of COPD
Eur. Respir. J., January 1, 2008; 31(1): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Gunen, S. S. Hacievliyagil, O. Yetkin, G. Gulbas, L. C. Mutlu, and E. In
The role of nebulised budesonide in the treatment of exacerbations of COPD
Eur. Respir. J., April 1, 2007; 29(4): 660 - 667.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.I. Syed, N.A. Patel, S. Jan, A. Shaikh, B. Grunden, and K. Morar
Symptomatic refractures after vertebroplasty in patients with steroid-induced osteoporosis.
AJNR Am. J. Neuroradiol., October 1, 2006; 27(9): 1938 - 1943.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. E. Caplan-Shaw, S. M. Arcasoy, E. Shane, D. J. Lederer, J. S. Wilt, M. K. O'Shea, V. Addesso, J. R. Sonett, and S. M. Kawut
Osteoporosis in Diffuse Parenchymal Lung Disease
Chest, January 1, 2006; 129(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
K. Templeton
Secondary Osteoporosis
J. Am. Acad. Ortho. Surg., November 1, 2005; 13(7): 475 - 486.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Rosen and J. N. Miner
The Search for Safer Glucocorticoid Receptor Ligands
Endocr. Rev., May 1, 2005; 26(3): 452 - 464.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
A A Ionescu
When should we suspect osteoporosis in patients with chronic airways disease?
Chronic Respiratory Disease, January 1, 2005; 2(1): 1 - 2.
[PDF]


Home page
ChestHome page
R. Aris, J. F. Donohue, and D. Ontjes
Inhaled Corticosteroids and Fracture Risk: Having Our Cake and Eating It Too
Chest, January 1, 2005; 127(1): 5 - 7.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. E. Bolton, A. A. Ionescu, K. M. Shiels, R. J. Pettit, P. H. Edwards, M. D. Stone, L. S. Nixon, W. D. Evans, T. L. Griffiths, and D. J. Shale
Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1286 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. D. Scanlon, J. E. Connett, R. A. Wise, D. P. Tashkin, T. Madhok, M. Skeans, P. C. Carpenter, W. C. Bailey, A. S. Buist, M. Eichenhorn, et al.
Loss of Bone Density with Inhaled Triamcinolone in Lung Health Study II
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1302 - 1309.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Gluck and G. Colice
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Chest, May 1, 2004; 125(5): 1859 - 1876.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. T. Leone, J. E. Fish, S. J. Szefler, and S. L. West
Systematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma: Collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology
Chest, December 1, 2003; 124(6): 2329 - 2340.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.A. Ionescu and E. Schoon
Osteoporosis in chronic obstructive pulmonary disease
Eur. Respir. J., November 2, 2003; 22(46_suppl): 64s - 75s.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900.
[Full Text] [PDF]


Home page
NEJMHome page
A. J. Busti, M. D. Vervan, S. D. Brouse, J. R. Hurst, G. C. Donaldson, J. A. Wedzicha, G. Rolla, C. Bucca, A. Salloum, T. Y. Elbaage, et al.
Prednisone for Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., September 25, 2003; 349(13): 1288 - 1290.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. E. Shea, S. C. Miller, D. C. Poole, and J. P. Mattson
Cortical bone dynamics, strength, and densitometry after induction of emphysema in hamsters
J Appl Physiol, August 1, 2003; 95(2): 631 - 634.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. D. Aaron, K. L. Vandemheen, P. Hebert, R. Dales, I. G. Stiell, J. Ahuja, G. Dickinson, R. Brison, B. H. Rowe, J. Dreyer, et al.
Outpatient Oral Prednisone after Emergency Treatment of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 26, 2003; 348(26): 2618 - 2625.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. A. Adler, H. L. Funkhouser, V. I. Petkov, B. L. Elmore, P. S. Via, C. T. McMurtry, and T. Adera
Osteoporosis in Pulmonary Clinic Patients: Does Point-of-Care Screening Predict Central Dual-Energy X-ray Absorptiometry?
Chest, June 1, 2003; 123(6): 2012 - 2018.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets
Systemic effects of chronic obstructive pulmonary disease
Eur. Respir. J., February 1, 2003; 21(2): 347 - 360.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. M. Singh, V. A. Palda, M. B. Stanbrook, and K. R. Chapman
Corticosteroid Therapy for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review
Arch Intern Med, December 9, 2002; 162(22): 2527 - 2536.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Katsura and K. Kida
A Comparison of Bone Mineral Density in Elderly Female Patients With COPD and Bronchial Asthma
Chest, December 1, 2002; 122(6): 1949 - 1955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. Marquis, R. Debigare, Y. Lacasse, P. LeBlanc, J. Jobin, G. Carrier, and F. Maltais
Midthigh Muscle Cross-Sectional Area Is a Better Predictor of Mortality than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., September 15, 2002; 166(6): 809 - 813.
[Abstract] [Full Text]


Home page
ChestHome page
E. F. Dubois, E. Roder, P. N. R. Dekhuijzen, A. E. Zwinderman, and D. H. Schweitzer
Dual Energy X-ray Absorptiometry Outcomes in Male COPD Patients After Treatment With Different Glucocorticoid Regimens*
Chest, May 1, 2002; 121(5): 1456 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. MALTAIS, J. OSTINELLI, J. BOURBEAU, A. B. TONNEL, N. JACQUEMET, J. HADDON, M. ROULEAU, M. BOUKHANA, J. B. MARTINOT, and P. DUROUX
Comparison of Nebulized Budesonide and Oral Prednisolone with Placebo in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease . A Randomized Controlled Trial
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 698 - 703.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. M. Biskobing
COPD and Osteoporosis
Chest, February 1, 2002; 121(2): 609 - 620.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
B Gudbjornsson, U I Juliusson, and F V Gudjonsson
Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice
Ann Rheum Dis, January 1, 2002; 61(1): 32 - 36.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Matsumoto, K. Ishihara, T. Hasegawa, B.-i. Umeda, A. Niimi, and M. Hino
Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients : A 4-Year Longitudinal Study
Chest, November 1, 2001; 120(5): 1468 - 1473.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
K. L. RICE, J. B. RUBINS, F. LEBAHN, C. M. PARENTI, P. G. DUANE, M. KUSKOWSKI, A. M. JOSEPH, and D. E. NIEWOEHNER
Withdrawal of Chronic Systemic Corticosteroids in Patients with COPD . A Randomized Trial
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 174 - 178.
[Abstract] [Full Text]


Home page
ChestHome page
F. Iqbal, J. Michaelson, L. Thaler, J. Rubin, J. Roman, and M. S. Nanes
Declining Bone Mass in Men With Chronic Pulmonary Disease* : Contribution of Glucocorticoid Treatment, Body Mass Index, and Gonadal Function
Chest, December 1, 1999; 116(6): 1616 - 1624.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. F. Goldstein, J. J. Fallon Jr, and R. Harning
Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease*
Chest, December 1, 1999; 116(6): 1733 - 1749.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
I. R. Reid
Glucocorticoid Osteoporosis: Reid IR Glucocorticoid osteoporosis J Intensive Care Med 1999, 14231-242
J Intensive Care Med, September 1, 1999; 14(5): 231 - 242.
[PDF]


Home page
NEJMHome page
D. E. Niewoehner, M. L. Erbland, R. H. Deupree, D. Collins, N. J. Gross, R. W. Light, P. Anderson, N. A. Morgan, and The Department of Veterans Affairs Cooperative Stu
Effect of Systemic Glucocorticoids on Exacerbations of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 24, 1999; 340(25): 1941 - 1947.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. BERNARD, F. WHITTOM, P. LEBLANC, J. JOBIN, R. BELLEAU, C. BÉRUBÉ, G. CARRIER, and F. MALTAIS
Aerobic and Strength Training in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., March 1, 1999; 159(3): 896 - 901.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society
  Red Transition